We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Can sertraline prevent depressive disorders following traumatic brain injury?
News

Can sertraline prevent depressive disorders following traumatic brain injury?

Can sertraline prevent depressive disorders following traumatic brain injury?
News

Can sertraline prevent depressive disorders following traumatic brain injury?

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Can sertraline prevent depressive disorders following traumatic brain injury?"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Depressive disorders are common following traumatic brain injury (TBI). So, can the antidepressant medication sertraline (commonly known by the trade name Zoloft) prevent the onset of depressive disorders following TBI?


Ricardo Jorge, MD, of the Baylor College of Medicine, Houston, and coauthors tackled that question in a new article published online by JAMA Psychiatry. The authors conducted a randomized clinical trial at a university hospital over four years with 24 weeks of follow-up. A total of 94 patients consented and were assigned to receive placebo (n=46) or sertraline (n=48) at a dose of 100 mg/day for 24 weeks or until a mood disorder developed.


See Also: Impact of traumatic brain injury on long-term memory explored


Results suggest sertraline at a low dose early after TBI appears to be an efficacious strategy to prevent depression after TBI but more study is needed before considering possible changes to treatment guidelines.


Limitations to the current study include its small sample size.


"Given the prevalence and functional effect of depression among patients with TBI, these findings have profound therapeutic implications. However, although our findings are novel and provocative, recommending a change in the guidelines to treat patients with TBI requires replication of these findings in multicenter studies. In addition, it would be important to study whether combining antidepressants with behavioral interventions, such as psychotherapy or cognitive rehabilitation protocols, will optimize long-term functional outcomes," the authors conclude.


Note: Material may have been edited for length and content. For further information, please contact the cited source.


JAMA   press release


Publication

Jorge RE et al. Sertraline for Preventing Mood Disorders Following Traumatic Brain Injury - A Randomized Clinical Trial.   JAMA Psychiatry, Published Online September 14 2016. doi: 10.1001/jamapsychiatry.2016.2189


Advertisement